Stroke Post Processing Software Market Size, Share & Trends Analysis Report By Installation (Desktop, Mobile Phones & Tablets), By Modality (CT Scan, MRI), By Type, By End-use, By Region, And Segment Forecasts, 2022 - 2030

Report Overview

The global stroke post processing software market size was valued at USD 143.1 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.2% from 2022 to 2030. Stroke is a time-critical condition, where every minute is sensitive. Stroke post processing software enables frontline physicians to make faster and more confident decisions regarding patient treatments and transfers. The software platforms offer stroke patients better treatment outcomes.

The implementation of stroke post processing software aids in reducing door-to-door-out time and helps patients achieve functional independence. In the initial stages, the COVID-19 pandemic impacted the market due to uncertainty as many healthcare services were shut down or restricted as precautionary guidelines to curb the spreading of the infection. However, the market conditions recovered due to the critical nature of the stroke.

The AI-based system helps stroke specialists to identify large vessel occlusions, enabling patient referral and transfer procedures to start sooner. The adoption of stroke post processing software facilitates the delivery of efficient pathways, makes faster treatment decisions, and achieves better outcomes for patients. Technological advancements, especially in the field of healthcare IT solutions, have significantly increased the adoption of software by healthcare providers while also mitigating the risk of complications post-stroke. With the availability of guiding software, stroke care professionals have gained the ability to collect and assess stroke data to make better treatment-related decisions.

The stroke post processing software provides more comprehensive pictures with synced data, which aids in the detection of the stroke's effect or progression and enables clinicians to make faster clinical decisions. Hence, to improvise quality and updates, investing in it can have a tremendous impact on the market growth. Government regulations that promote the overall adoption of healthcare IT solutions to improve healthcare outcomes act as a major strengthening factor for the market in both developed and developing regions. Well-defined laws and regulations require the companies to protect the patient data to safeguard the privacy rights of the consumers.

Installation Insights

In 2021, the desktop segment dominated the market for stroke post processing software and held a revenue share of over 60.0%. This can be attributed to quick accessibility, higher flexibility, easier data backup, and lower costs. Furthermore, the real-time tracking and storing of data, large storage space to store massive data, and remote access to other devices are likely to support the growth of the segment. Based on the installation, the market is segmented into desktops and mobile phones & tablets.

The mobile phones and tablets segment is anticipated to register the fastest growth rate from 2022 to 2030. Mobile phones and tablets offer innovative features such as access from any location, easy retrieval of patient data, and better data security and privacy. They offer better workflow integration to facilitate effective communication and coordination among frontline physicians dealing with stroke patients, resulting in accurate and quick treatments. In addition, the customization options including convenient installation, user-friendly functions, and complete operational control are contributing to the rising adoption of mobile phones and tablets for the use of stroke post processing software.

Modality Insights

The MRI segment dominated the market with a revenue share of over 70.0% in 2021 and is expected to witness the fastest growth from 2022 to 2030. A stroke is a weakening condition that negatively alters a patient’s quality of life, especially if left untreated at the earliest. Early diagnosis of stroke can reduce the patient’s chances of living with a disability. MRI testing offers a clear view of the head, including the tissue and blood vessels. An MRI reveals any changes in the brain by using magnetic fields and radiofrequency pulses. Based on modality, the market is segmented into CT scan and MRI.

CT scan takes several hours to reveal any blockages of blood flow. However, an MRI uncovers any brain damage within an hour of the onset of the stroke symptoms. In addition, MRIs are more accurate than CT scans as they are more sensitive. They show all issues that are related to strokes or brain-related factors. Furthermore, MRI is better at detecting even minor abnormalities that are too small to be detected by CT scans.

Type Insights

In 2021, the ischemic stroke segment held the largest revenue share of over 85.0% and is likely to register the fastest CAGR during the forecast period. When blood flow to a portion of the brain is disrupted due to a damaged or clogged blood artery, a stroke ensues. Strokes can be hemorrhagic or ischemic in nature. The kind of stroke determines the treatment. A head CT scan or an MRI can be used by doctors to determine the patient's condition. Based on type, the market is segmented into - ischemic stroke, hemorrhagic stroke, and others.

According to the John Hopkins University, over 87% of strokes are ischemic. Stroke is the second leading cause of death across the globe. A stroke occurs when the blood supply to the brain is disturbed suddenly. Ischemic stroke occurs when the blood supply to the brain tissues is limited, resulting in less oxygen. On the other hand, hemorrhagic stroke occurs when a blood vessel bursts and bleeds.

End-use Insights

In 2021, the hospitals and clinics segment dominated the market for stroke post processing software and captured a revenue share of over 75.0%. The segment is anticipated to expand at the fastest CAGR from 2022 to 2030. Hospitals and clinics are collaborating with key companies in an effort to manage stroke cases better by reducing treatment time. Based on end-use, the market is segmented into hospitals and clinics, & specialty centers and others.

For instance, Apollo Hospitals in India partnered with Medtronic for the integration of AI-based solutions for advanced stroke management in October 2020. The AI solutions offer automated analysis in less than two minutes, enabling faster decision-making in stroke. On the other hand, other conventional imaging procedures for stroke diagnosis take up to one hour to complete. Hence, the hospitals and clinics are adopting stroke post processing software.

Regional Insights

In 2021, North America held the leading share of over 45.0% in terms of revenue due to the factors such as the rising prevalence of stroke cases in the region, immense growth in the patient population, and supportive government investments for the development of better healthcare facilities. According to the U.S. Department of Health & Human Services, a stroke affects more than 795,000 people in the U.S. each year. As a result, hospitals and specialized centers in the U.S. and Canada are increasingly adopting stroke post processing software as it increases the visibility of vascular structures in the skull area and assists in the detection of aneurysms and other vascular disorders.

Asia Pacific is anticipated to grow at the fastest rate over the forecast period. This is owing to the rising awareness pertaining to treatment options, growing R&D in manufacturing, and improving healthcare infrastructure with technological advancements. Asia Pacific has faced several healthcare difficulties in the last decade, including an aging population and growth in the frequency of chronic illnesses due to sedentary lifestyles. As a result, healthcare requirements and expenses have risen across the region, compelling healthcare organizations to reconsider their approach to population health management.

Key Companies & Market Share Insights

A profound increase in R&D investments to design innovative AI-based solutions for stroke management is creating promising opportunities in the market. Hence, the key companies need to focus on digitization in order to attain and maintain their market positions. The rising relevance of digital imaging technologies and AI-driven diagnostic solutions is likely to reshape stroke management treatments.

Key market players are undertaking various initiatives to strengthen their position in the market. In October 2021, the healthcare vertical of General Electronic Company partnered with Circle Neurovascular Imaging to provide scientifically verified AI-driven solutions to improve acute stroke treatment. The company's extended FastStroke processing platform, which includes AI-based capabilities from Circle NVI, will aid frontline physicians in the triage and diagnosis of acute stroke.

In June 2021, Viz.ai'sAI-powered stroke care software received CE approval, indicating that it complies with European health, safety, and environmental protection regulations for items marketed inside the European Economic Area. In May 2021, Medtronic Inc. and Viz.ai announced their partnership that will be expanded to include Europe, the Middle East, and Africa in the distribution of Viz.ai's "lifesaving" (AI) software platform for stroke (EMEA). Some prominent players in the global stroke post processing software market include:

• Brainomix

• Viz.Ai, Inc.

• General Electric Company

• ISchemaView, Inc.

• Siemens

Stroke Post Processing Software Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the global stroke post processing software market report based on installation, modality, type, end-use, and region:

• Installation Outlook (Revenue, USD Million, 2017 - 2030)

  • Desktop

  • Mobile Phones & Tablets

• Modality Outlook (Revenue, USD Million, 2017 - 2030)

  • CT Scan

  • MRI

• Type Outlook (Revenue, USD Million, 2017 - 2030)

  • Ischemic Stroke

  • Hemorrhagic Stroke

  • Others

• End-use Outlook (Revenue, USD Million, 2017 - 2030)

  • Hospitals & Clinics

  • Specialty Centers & Others

• Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

  • Latin America

    • Brazil

    • Mexico

  • Middle East & Africa

    • South Africa